Choong Ang Vaccine Laboratory Co. Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.053x

Choong Ang Vaccine Laboratory Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Choong Ang Vaccine Laboratory Co. Ltd (072020) has a cash flow conversion efficiency ratio of 0.053x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.70 Billion ≈ $3.86 Million USD) by net assets (₩108.11 Billion ≈ $73.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Choong Ang Vaccine Laboratory Co. Ltd (2014–2025)

Cash flow conversion efficiency of Choong Ang Vaccine Laboratory Co. Ltd from 2014 to 2025. This chart illustrates how Choong Ang Vaccine Laboratory Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Choong Ang Vaccine Laboratory Co. Ltd (072020) stock price for real-time trading data and today's change.

Choong Ang Vaccine Laboratory Co. Ltd Cash Flow Conversion Ratio Explained

Choong Ang Vaccine Laboratory Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Choong Ang Vaccine Laboratory Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Choong Ang Vaccine Laboratory Co. Ltd ranked by their cash flow conversion efficiency. Also see Choong Ang Vaccine Laboratory Co. Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Dagi Giyim Sanayi ve Ticaret AS IS:DAGI	0.174x
Veritone Inc NASDAQ:VERI	-0.281x
IX Acquisition Corp. NASDAQ:IXAQF	-0.071x
Flanigans Enterprises Inc NYSE MKT:BDL	0.062x
Great Computer TWO:8047	-0.003x
Thryv Holdings Inc NASDAQ:THRY	0.101x
Guru Organic Energy Corp TO:GURU	-0.007x
Versatile Creative Bhd KLSE:4995	0.046x

Annual Cash Flow Conversion Efficiency for Choong Ang Vaccine Laboratory Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Choong Ang Vaccine Laboratory Co. Ltd from 2014 to 2025. Review Choong Ang Vaccine Laboratory Co. Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩105.37 Billion ≈ $71.41 Million	₩7.87 Billion ≈ $5.33 Million	0.075x	-42.10%
2024-12-31	₩103.87 Billion ≈ $70.39 Million	₩13.40 Billion ≈ $9.08 Million	0.129x	+1.35%
2023-12-31	₩99.80 Billion ≈ $67.64 Million	₩12.71 Billion ≈ $8.61 Million	0.127x	+71.24%
2022-12-31	₩95.30 Billion ≈ $64.59 Million	₩7.09 Billion ≈ $4.80 Million	0.074x	-40.02%
2021-12-31	₩92.98 Billion ≈ $63.01 Million	₩11.53 Billion ≈ $7.81 Million	0.124x	+30.51%
2020-12-31	₩87.55 Billion ≈ $59.33 Million	₩8.32 Billion ≈ $5.64 Million	0.095x	-1.15%
2019-12-31	₩86.37 Billion ≈ $58.53 Million	₩8.30 Billion ≈ $5.62 Million	0.096x	+43.06%
2018-12-31	₩85.00 Billion ≈ $57.61 Million	₩5.71 Billion ≈ $3.87 Million	0.067x	-42.55%
2017-12-31	₩64.68 Billion ≈ $43.83 Million	₩7.56 Billion ≈ $5.12 Million	0.117x	-8.46%
2016-12-31	₩60.37 Billion ≈ $40.91 Million	₩7.71 Billion ≈ $5.23 Million	0.128x	-29.41%
2015-12-31	₩54.88 Billion ≈ $37.19 Million	₩9.93 Billion ≈ $6.73 Million	0.181x	+41.03%
2014-12-31	₩51.99 Billion ≈ $35.23 Million	₩6.67 Billion ≈ $4.52 Million	0.128x	--

About Choong Ang Vaccine Laboratory Co. Ltd

KQ:072020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$56.71 Million

₩83.68 Billion KRW

Market Cap Rank

#21221 Global

#1237 in Korea

Share Price

₩9040.00

Change (1 day)

+1.01%

52-Week Range

₩8780.00 - ₩10140.00

All Time High

₩30815.73